← Leaderboards
Christy Shawn Carter
University Of Florida
$5,191,972
Attributed
$6,378,535
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$6,378,535 · 6
By mechanism
R01$4,126,299 · 3
P30$2,252,236 · 3
Top collaborators
- Thomas W Buford7 shared
- Steven N. Austad2 shared
Most similar at University Of Florida
Same institution · by research overlap
- Mohan K. Raizada$21,242,274
- Colin Sumners$12,690,977
- Eric Gerald Krause$10,526,367
- Annette Diane De Kloet$4,299,026
- Qiuhong Li$3,933,810
Others in their field
Top investigators on “Elderly”
- Charles A Coltman · Southwest Oncology Group$158,376,564
- Richard L Schilsky · University Of Chicago$122,071,723
- Michael W Weiner · Northern California Institute Res &Educ$99,760,701
- Monica M Bertagnolli · Strang Cancer Prevention Center$99,246,201
- Richard Mayeux · Columbia University Health Sciences$83,247,500
- Peter Gordon Gillespie · Oregon Health And Science University$80,983,248
Research focus
ElderlyAgingClinical TrialsPhysical FunctionDesignPreventionAreaCollaborationsPre-ClinicalFutureMaleDisabilityResourcesResearch PersonnelPreventInnovationBiologicalLongevityFatty Acid Glycerol EstersAmericanAngiotensinsAttenuatedClinical ResearchPharmaceutical Preparations
Grant awards (24)
Core B - Research Development Core$310,730
P30 · FY2022 · AG · contact PI
A sex difference approach to evaluating resilience as a predictor of healthspan in mice$304,425
R01 · FY2021 · AG
Pilot/Exploratory Studies Core (PESC)$256,440
P30 · FY2021 · AG · contact PI
Core B - Research Development Core$237,999
P30 · FY2021 · AG · contact PI
ACE2 as a novel therapeutic to preserve physical function in late life$213,098
R01 · FY2021 · AG
ACE2 as a novel therapeutic to preserve physical function in late life$304,425
R01 · FY2020 · AG
A sex difference approach to evaluating resilience as a predictor of healthspan in mice$304,425
R01 · FY2020 · AG
Core B - Research Development Core$237,412
P30 · FY2020 · AG · contact PI
Pilot/Exploratory Studies Core (PESC)$225,066
P30 · FY2020 · AG · contact PI
ACE2 as a novel therapeutic to preserve physical function in late life$304,425
R01 · FY2019 · AG
ACE2 AS A NOVEL THERAPEUTIC TO PRESERVE PHYSICAL FUNCTION IN LATE LIFE (Supplement 2)$269,979
R01 · FY2019 · AG
Pilot/Exploratory Studies Core (PESC)$224,767
P30 · FY2019 · AG · contact PI
ACE2 as a novel therapeutic to preserve physical function in late life$63,500
R01 · FY2019 · AG
ACE2 as a novel therapeutic to preserve physical function in late life$304,425
R01 · FY2018 · AG
Pilot/Exploratory Studies Core (PESC)$276,635
P30 · FY2018 · AG · contact PI
ACE2 as a novel therapeutic to preserve physical function in late life$304,425
R01 · FY2017 · AG
Pilot/Exploratory Studies Core (PESC)$283,069
P30 · FY2017 · AG · contact PI
PILOT AND EXPLORATORY STUDIES CORE$200,118
P30 · FY2012 · AG · contact PI
ACE Inhibition and Physical Performance in Aged Rats$428,188
R01 · FY2009 · AG · contact PI
ACE Inhibition and Physical Performance in Aged Rats$282,254
R01 · FY2008 · AG · contact PI
ACE Inhibition and Physical Performance in Aged Rats$141,749
R01 · FY2008 · AG · contact PI
ACE Inhibition and Physical Performance in Aged Rats$288,165
R01 · FY2007 · AG · contact PI
ACE Inhibition and Physical Performance in Aged Rats$297,756
R01 · FY2006 · AG · contact PI
ACE Inhibition and Physical Performance in Aged Rats$315,060
R01 · FY2005 · AG